Factors such as simplified and minimally invasive procedures, and wide range of applications; and improvements in comfort, efficiency, and outcomes with technological advancements propel the mesotherapy market growth. However, the potential side effects and regulatory challenges hamper the growth of the market.
The mesotherapy market in Asia Pacific is expected to grow at the highest CAGR during the forecast period. North America accounted for the largest share of the market in 2022. In 2022, North America held the largest market share. The increasing numbers of clinics and hospitals providing mesotherapy services, and an upsurge in government support to enhance the mesotherapy approach for cosmetic applications contribute to the expansion of the mesotherapy market size in North America. In the US, mesotherapy has gained acceptance as an excellent cosmetic treatment option owing to people’ preference for more effective, minimally invasive cosmetic procedures. It is also gaining more attention in applications such as pain management, sports medicine, and rheumatology. The demand for mesotherapy procedures is further likely to rise with the growing geriatric population in the country, especially to treat pain and facial aging signs.
Countries such as India, South Korea, Thailand, Saudi Arabia, Malaysia, Mexico, and the UAE have emerged as the world’s best medical tourism destinations. These countries are at the forefront of offering aesthetic services such as nose jobs, facelifts, lip jobs, liposuctions, and hair transplantation. Medical tourists from the US, Canada, and some European countries travel to the abovementioned countries to receive treatments for their health problems. According to the South Korean Ministry of Health and Welfare (MOHW), South Korea recorded a 70% increase in medical tourists from 2021 to 2022, with the number reaching ~248,000 in 2022 from 146,000 in 2021. As per the Society of Aesthetic Plastic Surgery, South Korea is among the countries performing the most number of plastic surgeries every year. Estimates by South Korean MOHW suggest that the country targets to attract ~700,000 international patients in 2027 with an aim to become a medical tourism hub in Asia. Therefore, with flourishing medical tourism, the demand for aesthetic procedures is likely to surge in developing countries, thereby bolstering the adoption of mesotherapy in the coming years. Low-cost procedures without any compromise on treatment quality, and reduced medical costs are the prime factors resulting in the growth of medical tourism, which, in turn, is expected to generate significant opportunities for the mesotherapy market growth in the coming years.
The Food and Drug Administration (FDA) has apporved a limited number of drugs for mesotherapy. According to the American Society of Plastic Surgeons (ASPS), once the FDA approves a drug, a licensed physician may prescribe a drug for use other than its indicated purpose. In the case of mesotherapy, multiple drugs or substances are combined to create a new formulation, which is not an FDA-approved practice. Thus, potential side effects and regulatory challenges hinders the mesotherapy market growth.
Mesotherapy Market: Segmental Overview
By product type, the market is segmented into mesotherapy solution kits, mesotherapy devices, mesotherapy filler kits, mesotherapy chemical peels, and anti-aging masks. The mesotherapy solution kits segment held the largest mesotherapy market share in 2022. The mesotherapy filler kits segment is anticipated to register the highest CAGR during the forecast period.
The market, by indication, is categorized into anti-aging and wrinkle treatment, facial rejuvenation, fat loss, hair loss, stretch marks, and acne and scar treatment. The anti-aging and wrinkle treatment segment held the largest mesotherapy market share in 2022. It is further anticipated to register the highest CAGR during the forecast period.
The market, by end user, is categorized into dermatology clinics, hospitals, cosmetic clinics, and others. The dermatology clinics segment held the largest share in mesotherapy market in 2022, and it is anticipated to register the highest CAGR during the forecast period.
The mesotherapy market report, based on geography, is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Mesotherapy Market: Competitive Landscape and Key Developments
Koru Pharma Co Ltd, Institute BCN Esthetics SL, Mesoskinline ApS, Colgate Palmolive Co, Skin Tech Pharma Group SL, HB Aesthetics Group SA, Toskani SL, Dr. Korman Laboratories Ltd, Revitacare SAS, Ostar Beauty Sci-Tech Co Ltd, Mesoestetic E-Commerce SL, Galderma SA, Derm Beauty International Sdn Bhd, and Mesotech Srl are among the prominent players profiled in the mesotherapy market report. These companies adopt product innovation strategies to meet evolving customer demands, which allows them to maintain their brand name in the market.
A few of the recent developments in the global market, as per company press releases, are mentioned below:
• In July 2023, PT Kalbe Farma Tbk (Kalbe) introduced mesotherapy products for aesthetic treatments in Indonesia. By entering into the aesthetic treatment market in this country, Kalbe aims to utilize opportunities presented by lifestyle trends, younger customer base, and rise in medical tourism in the country.
• In January 2022, Galderma received antitrust clearance from the US authorities and completed the acquisition of ALASTIN Skincare, a specialty aesthetics company dedicated to developing innovative and clinically tested physician-dispensed skincare products.